Truvian Sciences President and CEO Jeff Hawkins joins leaders of the nation’s most innovative labs to share new technologies and approaches to improve patient outcomes.
WHAT: | The Dark Intelligence Group’s Executive War College Conference on Laboratory & Pathology Management | |
WHEN: | General Session — Wednesday, April 27, 2022 at 11 a.m. | |
Rethinking the Clinical Laboratory Test Value Chain: Using New Technologies and New Approaches to Lower Costs, Speed Time-to-Answer, and Contribute to Improved Patient Outcomes | ||
General Session Panel — Wednesday, April 27, 2022 at 4:45 p.m. CDT | ||
Thinking Strategically: Spotting Opportunities Created by the Evolution of the Healthcare Value-Based Reimbursement, and New Technologies | ||
WHERE: | Hyatt Regency | |
601 Loyola Avenue | ||
New Orleans, LA 70113 | ||
WHO: | Jeff Hawkins, President and CEO of Truvian Sciences | |
CONTACT: | Michael Sullivan, media@truvianhealth.com |
For more information or to view the full agenda, visit: https://executivewarcollege.darkintelligencegroup.com/executive-war-college-agenda-2022
About Truvian Sciences
Truvian is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop system is being developed to produce lab-accurate results for a full-suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian’s system delivers a convenient and affordable alternative to off-site labs, providing immediate insights to inform healthcare decisions. Truvian was founded by individuals with deep domain experience in healthcare, diagnostics, and consumer technology. Today, the team has expanded to include top scientists, engineers, and healthcare business leaders — each bringing specialized expertise to drive Truvian’s mission of making routine health testing convenient, affordable, and actionable.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220427005423/en/
Michael Sullivan, media@truvianhealth.com
Source: Truvian Sciences
View this news release online at:
http://www.businesswire.com/news/home/20220427005423/en